SA
TLSA icon

Sanctuary Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Sanctuary Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-907,613
Closed -$864K – 2497
2024
Q3 		$864K Buy
+907,613
New +$917K 0.01% 1340

Other funds holding TLSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanctuary Advisors's TLSA Position: Q4 2024 in Review

Sanctuary Advisors sold out of Tiziana Life Sciences (TLSA) in Q4 2024, closing a stake of 907,613 shares — an estimated $864K sold.

Sanctuary Advisors first reported a position in TLSA in Q3 2024 and held it in 1 quarter. The position peaked at $864K in Q3 2024. 33 funds tracked by Wall St. Rank hold TLSA as of Q4 2024.

  • Sanctuary Advisors reported no remaining Tiziana Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Sanctuary Advisors sold 907,613 Tiziana Life Sciences shares in Q4 2024, an estimated $864K.
  • Sanctuary Advisors first reported a position in Tiziana Life Sciences in Q3 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Tiziana Life Sciences position peaked at $864K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2024.

Based on Sanctuary Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.